Ratings Verano Holdings Corp. OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 03:57:56 2024-04-26 pm EDT			5-day change	1st Jan Change
4.93 ^USD	+4.92%		-0.80%	+10.04%

Apr. 02	Pot producers climb as recreational cannabis to go on Florida ballot	RE
Mar. 15	Cannabis Stocks Gain Following Rumors of Imminent Rescheduling	DJ

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.

Low profitability weakens the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The group usually releases earnings worse than estimated.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
VERANO HOLDINGS CORP.	+10.04%	1.61B		-
GREEN THUMB INDUSTRIES INC.	+13.25%	2.78B		D+
TERRASCEND CORP.	+3.64%	464M		-
HIGH TIDE INC.	+29.11%	162M		-
CANTOURAGE GROUP SE	+13.51%	110M	-	-
MARIMED INC.	-2.98%	101M		-
NOVA CANNABIS INC.	+52.81%	56.08M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality